Mechanisms of glucagon-like-peptide 1 in the brain beyond metabolic effects
Ever since its discovery, glucagon-like-peptide 1 (GLP-1) and drugs with similar function (collectively GLP-1s) have been used for type 2 diabetes mellitus and have been effective for obesity. Their profound effect on weight loss has resulted in widespread use of these medicines for treating obesity...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Korean Society of Pediatric Endocrinology
2025-08-01
|
| Serie: | Annals of Pediatric Endocrinology & Metabolism |
| Soggetti: | |
| Accesso online: | http://e-apem.org/upload/pdf/apem-2448320-160.pdf |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|